The effects of some steroidal alkylating agents on experimental animal mammary tumor and leukemia systems.
D000230:Adenocarcinoma / Q000188:drug therapy; D000477:Alkylating Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D055598:Chemical Phenomena; D002621:Chemistry; D002784:Cholesterol / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004952:Esters / Q000627:therapeutic use; D004958:Estradiol / Q000627:therapeutic use; D004970:Estrone / Q000627:therapeutic use; D005260:Female; D007939:Leukemia L1210 / Q000188:drug therapy; D007942:Leukemia, Experimental / Q000188:drug therapy*; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy*; D009368:Neoplasm Transplantation; D014677:Pharmaceutical Vehicles; D010648:Phenylacetates / Q000627:therapeutic use; D051381:Rats; D013256:Steroids / Q000627:therapeutic use*
D000477:Alkylating Agents; D004952:Esters; D014677:Pharmaceutical Vehicles; D010648:Phenylacetates; D013256:Steroids; D004970:Estrone; D004958:Estradiol; D003520:Cyclophosphamide; D002784:Cholesterol